| Synthesis, chemical characterization, and μ-opioid receptor activity assessment of the emerging group of “nitazene” 2-benzylbenzimidazole synthetic opioids MM Vandeputte, K Van Uytfanghe, NK Layle, DM St. Germaine, DM Iula, ... ACS Chemical Neuroscience 12 (7), 1241-1251, 2021 | 70 | 2021 |
| In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances MM Vandeputte, A Cannaert, CP Stove Archives of toxicology 94 (11), 3819-3830, 2020 | 50 | 2020 |
| The rise and fall of isotonitazene and brorphine: two recent stars in the synthetic opioid firmament MM Vandeputte, AJ Krotulski, DM Papsun, BK Logan, CP Stove Journal of Analytical Toxicology 46 (2), 115-121, 2022 | 49 | 2022 |
| Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform L Vasudevan, M Vandeputte, M Deventer, E Wouters, A Cannaert, ... Biochemical pharmacology 177, 113910, 2020 | 42 | 2020 |
| First report on brorphine: the next opioid on the deadly new psychoactive substance horizon? N Verougstraete, MM Vandeputte, C Lyphout, A Cannaert, F Hulpia, ... Journal of Analytical Toxicology 44 (9), 937-946, 2020 | 38 | 2020 |
| Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole ‘nitazene’ synthetic … MM Vandeputte, AJ Krotulski, D Walther, GC Glatfelter, D Papsun, ... Archives of toxicology 96 (6), 1845-1863, 2022 | 32 | 2022 |
| Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using … KE Grafinger, MM Vandeputte, A Cannaert, A Ametovski, E Sparkes, ... Drug testing and analysis 13 (7), 1412-1429, 2021 | 31 | 2021 |
| Toxicological and pharmacological characterization of novel cinnamylpiperazine synthetic opioids in humans and in vitro including 2-methyl AP-237 and AP-238 MF Fogarty, MM Vandeputte, AJ Krotulski, D Papsun, SE Walton, ... Archives of Toxicology 96 (6), 1701-1710, 2022 | 21 | 2022 |
| Phenethyl-4-ANPP: a marginally active byproduct suggesting a switch in illicit fentanyl synthesis routes MM Vandeputte, AJ Krotulski, F Hulpia, S Van Calenbergh, CP Stove Journal of Analytical Toxicology 46 (4), 350-357, 2022 | 17 | 2022 |
| Activity-based reporter assays for the screening of abused substances in biological matrices A Cannaert, M Vandeputte, SMR Wille, CP Stove Critical reviews in toxicology 49 (2), 95-109, 2019 | 16 | 2019 |
| First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2 … MM Vandeputte, N Verougstraete, D Walther, GC Glatfelter, J Malfliet, ... Archives of toxicology 96 (6), 1865-1880, 2022 | 14 | 2022 |
| Validation of activity-based screening for synthetic cannabinoid receptor agonists in a large set of serum samples A Cannaert, M Vandeputte, S Hudson, DM Wood, PI Dargan, CP Stove Clinical chemistry 65 (2), 347-349, 2019 | 14 | 2019 |
| Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays MM Vandeputte, M Persson, D Walther, S Vikingsson, R Kronstrand, ... Archives of Toxicology 96 (3), 877-897, 2022 | 12 | 2022 |
| In vitro functional assays as a tool to study new synthetic opioids at the μ-opioid receptor: Potential, pitfalls and progress MM Vandeputte, L Vasudevan, CP Stove Pharmacology & Therapeutics 235, 108161, 2022 | 10 | 2022 |
| Synthesis, chemical characterization, and μ-opioid receptor activity assessment of the emerging group of “nitazene” 2-benzylbenzimidazole synthetic opioids. ACS Chem Neurosci … MM Vandeputte, K Van Uytfanghe, NK Layle, DM St Germaine, DM Iula, ... | 10 | 2021 |
| Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide MM Vandeputte, MHM Tsai, L Chen, GC Glatfelter, D Walther, CP Stove, ... Drug and Alcohol Dependence 249, 109939, 2023 | 8 | 2023 |
| Alkoxy chain length governs the potency of 2-benzylbenzimidazole ‘nitazene’opioids associated with human overdose GC Glatfelter, MM Vandeputte, L Chen, D Walther, MHM Tsai, L Shi, ... Psychopharmacology 240 (12), 2573-2584, 2023 | 4 | 2023 |
| Detection, chemical analysis, and pharmacological characterization of dipyanone and other new synthetic opioids related to prescription drugs MM Vandeputte, SE Walton, SA Shuda, DM Papsun, AJ Krotulski, ... Analytical and Bioanalytical Chemistry 415 (21), 5165-5180, 2023 | 3 | 2023 |
| In vitro μ‐opioid receptor activation potential of U10 and β‐U10, positional isomers of the synthetic opioid naphthyl U‐47700 MM Vandeputte, CP Stove Drug Testing and Analysis 16 (3), 323-326, 2024 | | 2024 |
| Alkoxy Chain Length Governs the In Vitro and In Vivo Potency of 2-Benzylbenzimidazole Opioids Implicated in Human Overdose Deaths M Baumann, D Walther, MM Vandeputte, MHM Tsai, L Chen, CP Stove, ... Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023 | | 2023 |
